homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

March 14, 2023

Drug behemoth Pfizer buys Bothell's Seagen for $43B

By TOM MURPHY and MICHELLE CHAPMAN
Associated Press

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug developer “continue innovating,” except with more resources than it would have alone, Pfizer Chairman and CEO Albert Bourla told analysts.


 
. . .


To read this story in full login or purchase a subscription.




Email or user name:
Password:
 
Forgot password? Click here.